4//SEC Filing
Bartushak Jaime 4
Accession 0001213900-25-090609
CIK 0001851484other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:10 PM ET
Size
8.4 KB
Accession
0001213900-25-090609
Insider Transaction Report
Form 4
Bartushak Jaime
Chief Financial Officer
Transactions
- Award
Common Stock
2025-09-19+825,000→ 825,000 total
Holdings
- 1,400,000
Stock Option (Right to Buy)
Exercise: $2.15Exp: 2033-07-05→ Common Stock (1,400,000 underlying) - 400,000
Stock Option (Right to Buy)
Exercise: $1.07Exp: 2034-12-12→ Common Stock (400,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- [F2]These options were granted on December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- [F3]These options vest over three years, beginning July 5, 2023, with 1/36th every month for the first year, and the 1/3 each on the second and third anniversary of the July 5, 2023, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
Documents
Issuer
CITIUS ONCOLOGY, INC.
CIK 0001851484
Entity typeother
Related Parties
1- filerCIK 0001725077
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 4:10 PM ET
- Size
- 8.4 KB